ALS Limited

Equities

ALQ

AU000000ALQ6

Business Support Services

Market Closed - Australian S.E. 01:10:09 2024-03-28 am EDT 5-day change 1st Jan Change
13.13 AUD +0.61% Intraday chart for ALS Limited -2.45% +2.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy MT
ALS to Acquire Nuvisan; Shares Down 5% MT
Transcript : ALS Limited, Nuvisan Pharma Holding Gmbh - M&A Call
ALS Limited agreed to acquire YORK Analytical Laboratories, Inc. CI
ALS Limited agreed to acquire Wessling Holding Gmbh & Co.Kg. CI
ALS Limited agreed to acquire the remaining 51% stake in Nuvisan Pharma Holding Gmbh. CI
Jarden Adjusts ALS' Price Target to AU$13.80 From AU$13.40, Keeps at Buy MT
Rimfire Pacific Mining Completes Air Core Drilling at Murga Project MT
ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024 CI
New entries in the Investor Asia portfolio Our Logo
Australian Shares Rise as Investors Await US Inflation Data for Rate Hike Clues MT
ALS Trims Interim Dividend as Fiscal H1 Profit Declines; CFO to Step Down; Shares Up 6% MT
Australian shares rise on broad-based gains; CBA inches higher RE
ALS Limited acquired 85.6% stake in Indtech Instruments Private Limited for AUD 18.6 million. CI
Transcript : ALS Limited, H1 2024 Earnings Call, Nov 14, 2023
ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024 CI
ALS Limited Appoints Heike Truöl as Chief Strategy Officer CI
Als Limited Announces Interim Dividend for the Period of Six Months Ending 30 September 2023, Payable on 14 December 2023 CI
ALS Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
ALS Limited acquired 100% stake in Proanaliz Group of Laboratories for AUD 5.1 million. CI
ALS Limited's Equity Buyback Plan Extended till August 27, 2024. CI
ALS Limited To Seek Acquisitions CI
Transcript : ALS Limited - Shareholder/Analyst Call
ALS Limited Announces Board Changes CI
Global markets live: Boeing, Google, Meta, Sonos... Our Logo
Chart ALS Limited
More charts
ALS Limited is an Australia-based company that is engaged in the provision of professional technical services. The Company provides services primarily in the areas of testing, measurement and inspection, supporting environmental monitoring, food and pharmaceutical quality assurance, and mining and mineral exploration. The Company’s segments include Commodities and Life Sciences. The Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
13.13 AUD
Average target price
12.8 AUD
Spread / Average Target
-2.50%
Consensus
  1. Stock
  2. Equities
  3. Stock ALS Limited - Australian S.E.
  4. News ALS Limited
  5. ALS : Posts Downbeat Fiscal H1 Net Profit; Shares Fall 3%